<p>Stock are paring gains on Friday, with the mood soured by reports that Gilead’s remdesivir flopped in its first randomized clinical trial. This time last week, investors were full of ho
<p>In the video, from earlier today, I outlined the "value area" where most of the trading activity has occurred over the last 9-10 days. That range is from about 1.0890 up to 1.0973 (
Leave a Comment